Cancer cells reprogram to metastatic state through the acquisition of platelet mitochondria

(Cell Reports 42, 113147, September 26, 2023) In the originally published version of this article, the picture of H&E in the vehicle group was not shown in Figure 4I, and the inserts of the platelet (normal) group and the platelet (A/R) group were not correct. The corrected figure appears below and also with the paper online. Also, in the originally published version of this article, the email addresses for two of the corresponding authors were incorrect and have now been updated in the paper online. The correct email address for Changqing Zhang is [email protected], and the correct email address for Junjie Gao is [email protected]. The authors apologize for these errors. Cancer cells reprogram to metastatic state through the acquisition of platelet mitochondriaZhang et al.Cell ReportsSeptember 19, 2023In BriefZhang et al. report that cancer cells are reprogrammed to a metastatic state through the acquisition of platelet mitochondria via the PINK1/Parkin-Mfn2 pathway. They discover that transferred platelet mitochondria drive metabolic shift and ROS reduction in cancer cells. Targeting platelet mitochondria is a potential treatment for cancer metastases. Full-Text PDF Open Access